Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
dystonia 17 | 1.000 | 0.038 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
spastic paraplegia 41 (autosomal dominant) | 1.000 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||||
|
Macular dystrophy, North Carolina type | 1.000 | 0.077 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
GTPase activating protein and VPS9 domains 1 | 1.000 | 0.077 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
NUT family member 2E | 1.000 | 0.115 | 1.5E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
rabenosyn, RAB effector | 1.000 | 2.3E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
spastic paraplegia 37 (autosomal dominant) | 1.000 | 0.077 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
double homeobox 4 like 1 (pseudogene) | 1.000 | 0.115 |
|
disease | 0.350 | None | 1.000 | 0 | 0 | 2007 | 2018 | |||||||||
|
spastic paraplegia 25 (autosomal recessive, with disc herniation) | 1.000 | 0.154 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
spinocerebellar ataxia 20 | 1.000 | 0.077 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
spastic paraplegia 32 (autosomal recessive) | 1.000 | 0.192 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
spastic paraplegia 34 (autosomal dominant) | 1.000 | 0.077 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
spinocerebellar ataxia 30 | 0.931 | 0.077 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
dystonia 21, torsion (autosomal dominant) | 0.931 | 0.077 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
spinocerebellar ataxia 37 | 0.931 | 0.115 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2018 | |||||||||
|
cyclic nucleotide gated channel subunit alpha 2 | 0.931 | 0.154 | 9.8E-04 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2015 | 2017 | ||||||||
|
schlafen family member 14 | 0.931 | 3.5E-09 |
|
disease | 0.700 | None | 1.000 | 1 | 0 | 2015 | 2016 | |||||||||
|
regulator of G protein signaling 9 binding protein | 0.931 | 2.3E-03 |
|
phenotype | 0.700 | limited | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||
|
spastic paraplegia 29 (autosomal dominant) | 0.931 | 0.077 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
zona pellucida glycoprotein 2 | 0.931 | 6.2E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
zona pellucida glycoprotein 2 | 0.931 | 6.2E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
chromosome 11 open reading frame 80 | 0.931 | 0.115 | 2.0E-09 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
cilia and flagella associated protein 43 | 0.931 | 0.038 | 1.3E-22 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
spastic paraplegia 19 (autosomal dominant) | 0.931 | 0.077 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
spastic paraplegia 24 (autosomal recessive) | 0.931 | 0.077 |
|
disease | 0.300 | None | 0 | 0 |